Insights On Outsourced Drug Development

31. Cost And Scalability Key Drivers Of Expanded Gene Therapy Access 5/16/2025

    Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

32. Inside Asymchem's Advanced R&D Capabilities In The UK 2/12/2026

    Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.

33. Simplify Cell Line Development 10/1/2025

    Explore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.

34. A Novel Patient-Derived Colorectal Cancer Organoid Platform 4/22/2025

    Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

35. Cell Culture Automation Of The 3D Cancer Spheroid Assay 3/24/2025

    Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

36. Validating Antibodies With Knock-Out Technologies 10/8/2024

    Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.

37. Ex Vivo Systems: Translating Mechanisms To Human Oncology 4/22/2024

    Watch to learn how Champions Oncology is advancing the development of oncology drugs through the creation of complex in vitro models using patient-derived TumorGrafts.

38. Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development 6/19/2025

    Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

39. Accelerating Method Development And Manufacturing Of GLP-1 Analogs 7/29/2025

    Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.

40. Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease 8/2/2024

    What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?